# Kymera Therapeutics (KYMR) — Overview

KYMR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/kymr

## Price

Last close $108.14 on Oct 15, 2026. 52-week range $55.80 – $127.31.

## Company profile

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $105.0M |
| Revenue (quarter) | $65.0M |
| Revenue growth (year over year) | 466.40% |
| Gross profit (trailing twelve months) | $105.0M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$299.6M |
| Net income (quarter) | −$61.2M |
| Net income growth (year over year) | 20.10% |
| Net margin | -285.33% |
| Return on equity | -24.15% |
| EPS (trailing twelve months) | −$3.25 |
| Book value per share | $18.23 |
| P/E (trailing twelve months) | — |
| Price to book | 6.0 |
| Debt to assets | 8.28% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Kymera Therapeutics (KYMR) profitable?

No. Kymera Therapeutics reported a net loss of $299.6M over the trailing twelve months.

### How much revenue does Kymera Therapeutics (KYMR) make?

Kymera Therapeutics generated $105.0M in revenue over the trailing twelve months, up 466.40% year over year.

### How do I buy stock in Kymera Therapeutics (KYMR)?

KYMR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).